{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:14Z","timestamp":1787020874346,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017501","name":"Science-Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["cstc2021jcyj-msxmX0006"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0006"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017501","name":"Science-Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2025MSXM113"],"award-info":[{"award-number":["2025MSXM113"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-024-01194-3","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T07:22:18Z","timestamp":1737012138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["68Ga-Pentixafor PET\/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism"],"prefix":"10.1186","volume":"15","author":[{"given":"MengDan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenBo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-3208","authenticated-orcid":false,"given":"Hua","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"1194_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. LANCET DIABETES ENDO. 2018;6:41\u201350. https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4.","journal-title":"LANCET DIABETES ENDO"},{"key":"1194_CR2","doi-asserted-by":"publisher","first-page":"101368","DOI":"10.1016\/j.beem.2019.101368","volume":"34","author":"J Funder","year":"2020","unstructured":"Funder J. Primary aldosteronism: treatment of the disease, and new therapeutic approaches. BEST PRACT RES CL EN. 2020;34:101368. https:\/\/doi.org\/10.1016\/j.beem.2019.101368.","journal-title":"BEST PRACT RES CL EN"},{"key":"1194_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/joim.12831","volume":"285","author":"WJ Young","year":"2019","unstructured":"Young WJ. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J INTERN MED. 2019;285:126\u201348. https:\/\/doi.org\/10.1111\/joim.12831.","journal-title":"J INTERN MED"},{"key":"1194_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","volume":"19","author":"PO Lim","year":"2001","unstructured":"Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J HYPERTENS. 2001;19:353\u201361. https:\/\/doi.org\/10.1097\/00004872-200103000-00001.","journal-title":"J HYPERTENS"},{"key":"1194_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese society of hypertension guidelines for the management of hypertension (jsh 2019). HYPERTENS RES. 2019;42:1235\u2013481. https:\/\/doi.org\/10.1038\/s41440-019-0284-9.","journal-title":"HYPERTENS RES"},{"key":"1194_CR6","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/ajh\/hpac079","volume":"35","author":"A Vaidya","year":"2022","unstructured":"Vaidya A, Hundemer GL, Nanba K, Parksook WW, Brown JM. Primary aldosteronism: state-of-the-art review. AM J HYPERTENS. 2022;35:967\u201388. https:\/\/doi.org\/10.1093\/ajh\/hpac079.","journal-title":"AM J HYPERTENS"},{"key":"1194_CR7","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/jch.13960","volume":"22","author":"H Zhang","year":"2020","unstructured":"Zhang H, Li Q, Liu X, Zhao Z, He H, Sun F, et al. Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: an efficacy and safety, proof-of-principle trial. J CLIN HYPERTENS. 2020;22:1618\u201326. https:\/\/doi.org\/10.1111\/jch.13960.","journal-title":"J CLIN HYPERTENS"},{"issue":"Suppl 2","key":"1194_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/ccd.29554","volume":"97","author":"H Dong","year":"2021","unstructured":"Dong H, Zou Y, He J, Deng Y, Chen Y, Song L, et al. Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial. CATHETER CARDIO INTE. 2021;97(Suppl 2):976\u201381. https:\/\/doi.org\/10.1002\/ccd.29554.","journal-title":"CATHETER CARDIO INTE"},{"key":"1194_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-024-01881-7","author":"X Li","year":"2024","unstructured":"Li X, Feng R, Xiang R, Tao L, Zhao YP, Tang P, et al. Bilateral superselective adrenal artery embolization for bilateral primary aldosteronism: a novel approach in an efficacy and safety proof-of-principle trial. HYPERTENS RES. 2024. https:\/\/doi.org\/10.1038\/s41440-024-01881-7.","journal-title":"HYPERTENS RES"},{"key":"1194_CR10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2214\/ajr.168.5.9129420","volume":"168","author":"H Inoue","year":"1997","unstructured":"Inoue H, Nakajo M, Miyazono N, Nishida H, Ueno K, Hokotate H. Transcatheter arterial ablation of aldosteronomas with high-concentration ethanol: preliminary and long-term results. AM J ROENTGENOL. 1997;168:1241\u20135. https:\/\/doi.org\/10.2214\/ajr.168.5.9129420.","journal-title":"AM J ROENTGENOL"},{"key":"1194_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1148\/radiol.2272011798","volume":"227","author":"H Hokotate","year":"2003","unstructured":"Hokotate H, Inoue H, Baba Y, Tsuchimochi S, Nakajo M. Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases. Radiology. 2003;227:401\u20136. https:\/\/doi.org\/10.1148\/radiol.2272011798.","journal-title":"Radiology"},{"key":"1194_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1053\/j.semnuclmed.2023.09.002","volume":"54","author":"L Lindenberg","year":"2024","unstructured":"Lindenberg L, Ahlman M, Lin F, Mena E, Choyke P. Advances in pet imaging of the cxcr4 receptor: [(68)Ga]Ga-pentixafor. SEMIN NUCL MED. 2024;54:163\u201370. https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.09.002.","journal-title":"SEMIN NUCL MED"},{"key":"1194_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, et al. Targeting cxcr4 (cxc chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma. Hypertension. 2018;71:317\u201325. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09975.","journal-title":"Hypertension"},{"key":"1194_CR14","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","volume":"47","author":"J Ding","year":"2020","unstructured":"Ding J, Zhang Y, Wen J, Zhang H, Wang H, Luo Y, et al. Imaging cxcr4 expression in patients with suspected primary hyperaldosteronism. EUR J NUCL MED MOL I. 2020;47:2656\u201365. https:\/\/doi.org\/10.1007\/s00259-020-04722-0.","journal-title":"EUR J NUCL MED MOL I"},{"key":"1194_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders J, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. LANCET DIABETES ENDO. 2017;5:689\u201399. https:\/\/doi.org\/10.1016\/S2213-8587(17)30135-3.","journal-title":"LANCET DIABETES ENDO"},{"key":"1194_CR16","first-page":"154","volume":"54","author":"H Inoue","year":"1994","unstructured":"Inoue H, Nakajo M, Miyazono N, Kanetsuki I, Miyake S, Hokotate H, et al. Treatment of aldosteronoma with superselective intraarterial injection of absolute ethanol. Nihon Igaku Hoshasen Gakkai Zasshi. 1994;54:154\u201362.","journal-title":"Nihon Igaku Hoshasen Gakkai Zasshi"},{"key":"1194_CR17","doi-asserted-by":"publisher","first-page":"e13353","DOI":"10.1111\/ijcp.13353","volume":"73","author":"PM O\u2019Shea","year":"2019","unstructured":"O\u2019Shea PM, Griffin TP, Denieffe S, Fitzgibbon MC. The aldosterone to renin ratio in the diagnosis of primary aldosteronism: promises and challenges. INT J CLIN PRACT. 2019;73:e13353. https:\/\/doi.org\/10.1111\/ijcp.13353.","journal-title":"INT J CLIN PRACT"},{"key":"1194_CR18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/RLU.0000000000004369","volume":"47","author":"CC Lu","year":"2022","unstructured":"Lu CC, Chen CJ, Peng KY, Chueh JS, Chang CC, Yen RF, et al. Predicting treatment response in primary aldosteronism using 11 c-metomidate positron emission tomography. CLIN NUCL MED. 2022;47:936\u201342. https:\/\/doi.org\/10.1097\/RLU.0000000000004369.","journal-title":"CLIN NUCL MED"},{"key":"1194_CR19","doi-asserted-by":"publisher","unstructured":"Mendichovszky IA, Powlson AS, Manavaki R, Aigbirhio FI, Cheow H, Buscombe JR, et al. Targeted molecular imaging in adrenal disease-an emerging role for metomidate pet-ct. DIAGNOSTICS. 2016;6. https:\/\/doi.org\/10.3390\/diagnostics6040042.","DOI":"10.3390\/diagnostics6040042"},{"key":"1194_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1210\/jc.2011-1537","volume":"97","author":"TJ Burton","year":"2012","unstructured":"Burton TJ, Mackenzie IS, Balan K, Koo B, Bird N, Soloviev DV, et al. Evaluation of the sensitivity and specificity of (11)c-metomidate positron emission tomography (pet)-ct for lateralizing aldosterone secretion by conn\u2019s adenomas. J CLIN ENDOCR METAB. 2012;97:100\u20139. https:\/\/doi.org\/10.1210\/jc.2011-1537.","journal-title":"J CLIN ENDOCR METAB"},{"key":"1194_CR21","doi-asserted-by":"publisher","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","volume":"6","author":"J Hu","year":"2023","unstructured":"Hu J, Xu T, Shen H, Song Y, Yang J, Zhang A, et al. Accuracy of gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism. JAMA NETW OPEN. 2023;6:e2255609. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55609.","journal-title":"JAMA NETW OPEN"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-024-01194-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-024-01194-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-024-01194-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T07:22:20Z","timestamp":1737012140000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-024-01194-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1194"],"URL":"https:\/\/doi.org\/10.1186\/s13550-024-01194-3","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in strict accordance with the ethical principles of the Declaration of Helsinki and received formal approval from the Ethics Review Committee of the First Affiliated Hospital of Chongqing Medical University (Approval Number: 2024-135-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this study and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no potential conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}